2x founder

Rachel Gate

Strategic Initiatives @ Xaira | AI Platforms | AI-native Drug Discovery

Co-founder

2025Director Strategic Initiatives· Xaira Therapeutics

Founder · since 2019

Company

Xaira Therapeutics

Role

Director Strategic Initiatives

current

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Profile coverage5 of 7 · missing posts, contact

Dropprint Genomics

The better way to run single cell genomics

Experience

Career

Xaira Therapeutics
Director Strategic Initiatives · 2025 – Present
2025
10x Genomics
Co-founder
Associate Director, Emerging Businesses · 2023 – 2025
2023
10x Genomics
Business Insights and Strategy Lead · 2022 – 2023
2022
Immunai
Product Manager · 2021 – 2022
2021
Immunai
Senior Machine Learning Scientist · 2020 – 2021
2020
Dropprint Genomics
Founder
Chief Executive Officer · San Francisco Bay Area · 2019 – 2020
2019
University of California, San Francisco
Biological and Medical Informatics PhD · Institute of Human Genetics · 2014 – 2019
2014
University of California, San Francisco
Biostatistics Teachers Assistant · San Francisco Bay Area · 2016
2016
UCSF
Staff Research Associate · University of California, San Francisco · 2012 – 2014
2012
Abbott Laboratories
Associate Scientist II · Redwood City, CA · 2012
2012
Santa Clara University
Undergraduate Researcher · Santa Clara, CA · 2010 – 2012
2010
Santa Clara University
Chemistry Tutor · Santa Clara, CA · 2009 – 2012
2009
Santa Clara University
Chemistry and Biochemistry Lab Assistant · Santa Clara, CA · 2009 – 2012
2009

PhD bioinformatics (UCSF) | Cofounder of Dropprint Genomics (W20; acquired by Immunai) | Currently building out new businesses lines in biotech